Steroid Devices in Retinal Diseases - San Francisco, CA

Steroid Devices in Retinal Diseases:

A Paradigm Shift in Combination Treatment

Date and Time
Wednesday, April 30, 2014
6:00pm - 8:00pm

Location
Farallon
450 Post Street
San Francisco, CA 94102

Agenda
6:00pm - 6:30pm Registration
6:30pm - 8:00pm Educational Session and Dinner

Faculty

Rishi Singh, MD

Staff Member
Department of Ophthalmology
Cleveland Clinic
Cole Eye Institute
Cleveland, OH

Jason Bacharach, MD

Director of Research
North Bay Eye Associates, Inc.
Sonoma, CA
Vice Chair, Glaucoma Department
California Pacific Medical Center
San Francisco, CA

Learning Objectives:
Upon completion of this activity, the participant should be able to:

• Understand the potential for corticosteroid therapy to induce complications,
including elevated IOP
• Distinguish between the different classes of corticosteroid therapy and relate
the risks for complications associated with each
• Explain the early warning signs of elevated IOP
• Identify effective management strategies for patients requiring intervention

CME Information

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Dulaney Foundation and Retina Today. The Dulaney Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Dulaney Foundation designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For more information, please visit: www.SDRDseries.com